Tirzepatide Cost: What a Month Really Runs

What tirzepatide costs depends almost entirely on which door you buy it through, so here are all three, priced as of August 2026. Brand-name Zepbound, bought self-pay through Lilly's own channel, runs $299 to $699 for a month's supply depending on your dose — Lilly's published regular prices are $299 at 2.5 mg, $399 at 5 mg, $499 at 7.5 mg and $699 at 10, 12.5 and 15 mg⁶. With commercial insurance that covers the drug, Lilly's savings card brings Zepbound or Mounjaro down to as little as $25 a month⁶⁷. And compounded tirzepatide through telehealth ran a median of about $289 a month in our own checks, across a range of roughly $169 to $399 — counting only providers where a true month-to-month figure is knowable at all, because 18 of the 20 we examined attach a prepay or commitment mechanism to the price they advertise.

One more number belongs in the first paragraph because everyone's math quietly depends on it: in Lilly's own terms, a "month" is defined as 28 days⁶⁷. Twelve calendar months of a 28-day cycle is thirteen fills, and Lilly's savings cards cap at a maximum of 13 fills per calendar year for exactly that reason⁷. Whatever monthly figure you settle on, your annual cost is that figure times thirteen, not twelve.

What Mounjaro and Zepbound Cost at the Brand Counter

Mounjaro and Zepbound are the same molecule — tirzepatide, a dual GIP and GLP-1 receptor agonist — under two labels: Mounjaro is approved for type 2 diabetes, Zepbound for chronic weight management and obstructive sleep apnea⁹. The trials behind them are the reason the drug commands its price: in SURMOUNT-1, 72 weeks of weekly tirzepatide produced mean weight reductions of 15.0%, 19.5% and 20.9% at the 5, 10 and 15 mg doses against 3.1% for placebo¹, and in the SURPASS-2 head-to-head it beat semaglutide 1 mg on both glycated hemoglobin and weight in type 2 diabetes³.

What Lilly publishes is not one price but a price per pathway, and reading its own pages makes the structure clear⁶⁷:

• •Commercially insured, drug covered: as little as $25 for a one-, two- or three-month prescription fill with the savings card, for either product⁶⁷.
• •Commercially insured, drug not covered: a card rate of $499 for a one-month fill of the Mounjaro or Zepbound single-dose pen⁶⁷.
• •Self-pay, no insurance involved: Zepbound's published regular prices per one-month supply of the single-patient-use KwikPen — $299 at 2.5 mg, $399 at 5 mg, $499 at 7.5 mg, $699 at 10, 12.5 and 15 mg — with the $299 tile also covering a month as four vials⁶.

Two details in the fine print are worth knowing before you treat those as simple sticker prices. First, the doses most people actually maintain on are discounted by a purchase offer: Lilly applies a $449 rate to the 7.5 through 15 mg KwikPens, and keeping it requires completing each refill purchase on schedule — miss the window and the regular price applies⁶. A conditional discount that depends on refilling on time is a commitment mechanism, and it is instructive that even the manufacturer's own channel uses one. Second, the $25 and $499 card figures exclude government beneficiaries; the separate Medicare GLP-1 Bridge line on Lilly's page quotes "no more than $50/month" for eligible Medicare Part D patients with a weight-management prescription, explicitly not guaranteed⁶.

What You Actually See on LillyDirect

LillyDirect is Lilly's own front door: it connects you to independent telehealth providers and fills the prescription through its home-delivery pharmacy. The drug prices above do not include the clinician. On the LillyDirect page itself, the listed obesity-care options run about $25 to $31 per visit on average with insurance, while the self-pay routes are $100 to $299 per visit or membership programs at $99 to $149 a month, with annual-rate discounts down to $59 and $74⁸.

That layering matters for comparison shopping. A $399 Zepbound month at 5 mg plus a $100 self-pay visit is a different total than a compounded provider's $289 with the consultation included — and most telehealth compounders do fold the clinician into the monthly price, which is part of how they compete. The honest comparison is always the full stack: drug, clinician, labs, shipping.

Will Insurance Cover Tirzepatide?

The coverage question splits cleanly along the two labels. Mounjaro's diabetes indication is the better-covered one; Zepbound's weight-management indication is where plans diverge, because many commercial plans and most government programs treat weight-loss drugs as an excluded category. Lilly's own card structure tells you this is common: the company maintains a specific $499 pathway for people who have commercial insurance that does not cover the drug⁶⁷ — a product that would not exist if coverage were the norm.

There is no way for any article to tell you what your plan does. The check that works is two calls: your plan's pharmacy benefit line, asking specifically whether tirzepatide is covered under the indication your prescription will carry, and your pharmacy, asking what the card brings your fill to. If the answer is no coverage, the self-pay ladder above and the compounded market below are the actual choices, and our semaglutide cost breakdown and semaglutide provider rankings cover the cheaper sibling molecule — the tirzepatide versus semaglutide comparison is the place to weigh whether the price gap is worth it in your case³.

Compounded Tirzepatide Through Telehealth: Our Verified Numbers

Across the compounded tirzepatide providers we checked in August 2026, the median true month-to-month price was about $289, with a range of roughly $169 to $399 — and that sentence carries a load-bearing qualifier. A true month-to-month figure — what you pay this month with the freedom to stop next month — is only knowable for some providers, because 18 of the 20 we examined attach a prepay or commitment mechanism to the number they advertise: a multi-month prepay rung printed without its term, a first-month teaser standing in for an ongoing rate, an auto-refill enrollment, or a markdown with no stated unlock. The per-provider rows, with each mechanism named, live on our tirzepatide rankings and on cheapest tirzepatide online, which ranks by the absolute floor price with the lever labeled next to it; the price transparency index tracks who publishes what.

The floor of that range illustrates how fast this market moves. When we verified it in early August 2026, yourEra listed tirzepatide at a flat $169 a month with no prepay lever behind it — the lowest confirmed no-commitment rate in our ranking. By late August the same homepage advertised "from $159/mo" instead: a lower-looking floor whose qualifying term is published nowhere. Most advertised figures at that end of the market are the bottom rung of a commitment ladder with the commitment left off, and a "from" price with no published ladder is that pattern with one more step removed. Trimi's "$125 per month" tirzepatide is the fully-loaded version: the fine print beside it reads "$1,500 billed once yearly", the plain monthly rate is $235, and the refund policy makes the order final once a prescription is issued. At the other end of the disclosure spectrum, Willow prints tirzepatide at a flat $399 a month — a real recurring figure, with the caveat that dose-tier costs are unpublished and its named partner-pharmacy list includes one with an FDA warning letter on file.

Compounded tirzepatide is also a different product category, not a discounted Zepbound. The FDA's standing position is that compounded drugs do not undergo its review for safety, effectiveness or quality, and that compounded versions should only be used when medical needs cannot be met by an approved drug¹¹. The agency has separately warned about dosing errors with compounded injectable GLP-1 drugs, where vials labeled in milligrams meet syringes marked in units¹⁰ — the arithmetic is covered in tirzepatide dosage, and the tirzepatide dosage calculator, reconstitution calculator and insulin syringe units converter do the conversion from your own vial's numbers. The regulatory ground also moves: is compounded semaglutide or tirzepatide still legal and the peptide FDA status tracker follow the primary record, and how to verify a COA is the practical check on what is actually in a compounded vial.

Does the Price Hold When Your Dose Goes Up?

This is the question a first-month quote is least likely to answer, and it is built into the drug. The labeled schedule starts everyone at 2.5 mg weekly for four weeks — a starting dose, not a maintenance one — and steps up in 2.5 mg increments to a maintenance dose of 5, 10 or 15 mg⁹. The trial results people are buying were produced at those maintenance doses¹², so the dose you price in month one is not the dose you will likely be paying for in month six.

The two markets answer differently. Brand-name Zepbound is explicitly dose-tiered: the self-pay ladder more than doubles from $299 at the starting dose to $699 at the top three strengths⁶. Compounded providers split — some tier by dose, some publish one flat rate. The flat kind is worth real money at escalation time, and the providers who commit to it in writing are rare enough to name: Enhance MD prints "Same Pricing — All Doses" on its product pages as a stated policy, at a $329 sticker for tirzepatide — among the highest rates in our ranking, but one that cannot quietly grow as your dose does. Two cadence caveats: every tier is billed on four-week cycles, so the "/mo" labels understate a calendar month by roughly 8.7% (the $329 sticker is really about $358 a month), and the advertised "$280/month" is a $3,360 prepay covering forty-eight weeks — the same lever pattern as everywhere else, sitting on top of a genuinely honest dose policy.

So when comparing any two tirzepatide quotes, compare them at a named dose, and ask the flat-or-tiered question before the first payment. A $229 price that becomes $429 at 10 mg is not cheaper than a flat $329.

What Is Bundled and What Is Extra

The advertised number is rarely the whole invoice, and what rides along varies more than the prices do:

• •The clinician. Included in most compounded telehealth prices; separate on the brand path, where LillyDirect's connected visits are billed by the telehealth provider⁸.
• •Labs. Usually not required or not included; Enhance MD is an exception that bundles metabolic labs at Quest into onboarding.
• •Shipping, syringes and supplies. Sometimes itemized, sometimes silent. A silent line item is a question to ask, not a free one.
• •The exit. The most expensive extra is the one 18 of 20 providers attach: a term. A price you can only get by prepaying months you may not want is not that price.

Budget for the Real Horizon

Tirzepatide's cost question is ultimately a duration question, and the trial record is blunt about it. In SURMOUNT-4, participants who lost 20.9% of body weight over 36 weeks and were then switched to placebo regained 14.0% over the following year, while those who continued lost a further 5.5% — 89.5% of continuers kept at least 80% of the loss versus 16.6% on placebo⁴. The longest data now run three years of continuous weekly treatment, with weight reductions sustained and progression to type 2 diabetes cut sharply in people with obesity and prediabetes⁵. This is a drug whose result persists while the prescription — and the bill — does.

So do the honest multiplication: thirteen 28-day fills a year puts the confirmed compounded floor of $169 at about $2,200 a year, the $289 median at about $3,750, and top-dose self-pay Zepbound at about $9,100⁶. That horizon is also why the questions adjacent to price matter — muscle loss on GLP-1 drugs, what microdosing tirzepatide does and does not have evidence for, and how the class fits the wider weight-loss injection landscape. If you are pricing the next molecule over, retatrutide cost and retatrutide versus tirzepatide cover why that market barely publishes prices at all.

The bottom line, as of August 2026: covered commercial insurance is the cheap door at $25 a month if your plan opens it⁶⁷; self-pay brand Zepbound is $299 to $699 by dose with a refill-conditional discount in the middle strengths⁶; and compounded telehealth medians about $289 with a confirmed floor of $169 — behind advertised numbers that, 18 times out of 20 in our checks, carry a lever the headline does not mention. Price it at your maintenance dose, times thirteen.

This page is educational and not medical advice. Whether tirzepatide is appropriate for you, and at what dose, is a decision for a licensed clinician who knows your history.